Chronic musculoskeletal pain in chronic fatigue syndrome: Recent developments and therapeutic implications

Manual Therapy

Volumn 11, Issue 3, 2006, Pages 187-191

  Nijs, Jo ^a,b   Meeus, Mira ^a,b   De Meirleir, Kenny ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b Division of Musculoskeletal Physiotherapy   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADDUCTION; ARTICLE; CHRONIC FATIGUE SYNDROME; GONIOMETRY; HUMAN; JOINT HYPERMOBILITY; MUSCULOSKELETAL PAIN; MYALGIA; NEUROPHYSIOLOGY; OXIDATIVE STRESS; PAIN THRESHOLD; PRIORITY JOURNAL;

FATIGUE SYNDROME, CHRONIC; HUMANS; PAIN MEASUREMENT; PHYSICAL THERAPY MODALITIES;

EID: 33746531152     PISSN: 1356689X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.math.2006.03.008     Document Type: Article

References (54)

1. Banic B., Petersen-Felix S., Andersen O.K., et al. Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain 107 (2004) 7-15
2. Bazan N.G. COX-2 as a multifunctional neuronal modulator. Nature Medicine 7 (2001) 414-415
3. Beighton P.H., Solomon L., and Soskolne C.L. Articular mobility in an African population. Annals of the Rheumatic Diseases 32 (1973) 413-417
4. Bombardier C.H., and Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use. Medical Care 34 (1996) 924-930
5. CFS/ME Working Group. Report to the Chief Medical Officer of an independent working group, Department of Health, London, 2001. www.doh.gov.uk/cmo/cfsmereport/index.htm.
6. Deale A., Chalder T., Marks I., and Wessely S. Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial. American Journal of Psychiatry 154 (1997) 408-414
7. Edmonds M, McGuire H, Price J. Exercise therapy for chronic fatigue syndrome. Cochrane Database Systematic Reviews. 2004;3:CD003200.pub2. doi:10.1002/14651858.CD003200.pub2.
8. Evengard B., Nilsson C.G., Lindh G., Lindquist, Eneroth P., Fredrikson S., et al. Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 78 (1998) 153-155
9. Fischler B., Dendale P., Michiels V., Cluydts R., Kaufman L., and De Meirleir K. Physical fatigability and exercise capacity in chronic fatigue syndrome: association with disability, somatization and psychopathology. Journal of Psychosomatic Research 42 (1997) 369-378
10. Fukuda K., Straus S., Hickie I., et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of Internal Medicine 121 (1994) 953-959
11. Fulcher K.Y., and White P.D. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. British Medical Journal 314 (1997) 1647-1652
12. Grahame R., Bird H.A., and Child A. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). Journal of Rheumatology 27 (2000) 1777-1779
13. Holmes G., Kaplan J., Gantz J., et al. Chronic fatigue syndrome: a working case definition. Annals of Internal Medicine 108 (1988) 387-389
14. Jammes Y., Steinberg J.G., Mambrini O., Brégeon F., and Delliaux S. Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. Journal of Internal Medicine 257 (2005) 299-310
15. Johnson S.K., DeLuca J., and Natelson B.H. Assessing somatization disorder in the chronic fatigue syndrome. Psychosomatic Medicine 58 (1996) 50-57
16. Kennedy G., Spence V.A., McLaren M., Hill A., Underwood C., and Belch J.J. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radical Biology and Medicine 39 5 (2005) 584-589
17. Kurup R.K., and Kurup P.A. Hypothalamic digoxin, cerebral chemical dominance and myalgic encephalomyelitis. International Journal of Neuroscience 113 (2003) 683-701
18. Levine P.H., Whiteside T.L., Friberg D., et al. Dysfunction of natural killer cell activity in a family with chronic fatigue syndrome. Clinical Immunology and Immunopathology 88 1 (1998) 99-104
19. Maier S.F., and Watkins L.R. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychological Review 105 (1998) 83-107
20. Meyer R.A., Campbell J.N., and Raja S.N. Peripheral neural mechanisms of nociception. In: Wall P.D., and Melzack R. (Eds). Textbook of Pain. third ed (1995), Churchill Livingstone, Edinburgh 13-44
21. Moseley L. Combined phsyiotherapy and education is efficacious for chronic low back pain. Australian Journal of Physiotherapy 48 (2002) 297-302
22. Moseley G.L., Nicholas M.K., and Hodges P.W. A randomized controlled trial of intensive neurophysiology education in chronic low back pain. Clinical Journal of Pain 20 (2004) 324-330
23. Nijs J. Generalized joint hypermobility: an issue in fibromyalgia and chronic fatigue syndrome? (review). Journal of Bodywork and Movement Therapies 9 (2005) 310-317
24. Nijs J., Nicolson G.L., De Becker P., Coomans D., and De Meirleir K. High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients. FEMS Immunology and Medical Microbiology 34 (2002) 209-214
25. Nijs J., Vaes P., McGregor N., Van Hoof E., and De Meirleir K. Psychometric properties of the Dutch Chronic Fatigue Syndrome Activities and Participation Questionnaire (CFS-APQ). Physical Therapy 83 (2003) 444-454
26. Nijs J., De Becker P., De Meirleir K., Demanet C., Vincken W., Schuermans D., et al. Associations between immune cell parameters and bronchial hyperresponsiveness in patients with chronic fatigue syndrome. Chest 123 (2003) 998-1007
27. Nijs J., Cloostermans B., McGregor N., Vaes P., and De Meirleir K. Construct validity and internal consistency of the chronic fatigue syndrome activities and participation questionnaire (CFS-APQ). Physiotherapy Theory and Practice 20 (2004) 31-40
28. Nijs J., De Meirleir K., and Truyen S. Hypermobility in patients with chronic fatigue syndrome: preliminary observations. Journal of Musculoskeletal Pain 12 (2004) 9-17
29. Nijs J., De Meirleir K., and Duquet W. Kinesiophobia in chronic fatigue syndrome: assessment and associations with disability. Archives of Physical Medicine and Rehabilitation 85 (2004) 1586-1592
30. Nijs J., Vanherberghen K., Duquet W., and De Meirleir K. Chronic fatigue syndrome: lack of association between pain-related fear of movement and exercise capacity and disability. Physical Therapy 84 (2004) 696-705
31. Nijs J., Meeus M., McGregor N.R., Meeusen R., De Schutter G., Van Hoof E., et al. Chronic fatigue syndrome: exercise performance related to immune dysfunction. Medicine and Science in Sports and Exercise 37 (2005) 1647-1654
32. Nijs J., Aerts A., and De Meirleir K. Generalized joint hypermobility is more common in chronic fatigue syndrome than in healthy controls. Journal of Manipulative and Physiological Therapeutics 29 (2006) 32-39
33. Nijs, J., Van de Putte, K., Louckx, F., Truyen, S., De Meirleir, K. under review. Exercise performance and chronic pain in chronic fatigue syndrome: the role of pain catastrophizing.
34. Nishikai M., Tomomatsu S., Hankins R.W., Takagi S., Miyachi K., Kosaka S., et al. Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders. Rheumatology 40 (2001) 806-810
35. Paul L., Wood L., Behan W.M.H., and Maclaren W.M. Demonstration of delayed recovery from fatiguing exercise in chronic fatigue syndrome. European Journal of Neurology 6 (1999) 63-69
36. Price JR, Couper J. Cognitive behaviour therapy for chronic fatigue syndrome in adults. Cochrane Database Systematic Reviews 1998;4:CD001027. doi:10.1002/14651858.CD001027.
37. Price D.D., Staud R., Robinson M.E., et al. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 99 (2002) 49-59
38. Prins J.B., Bleijenberg, Bazelmans E., Elving L.D., de Boo T.M., Severens J.L., et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicenter randomised controlled trial. Lancet 357 (2001) 841-847
39. Powell P., Bentall R.P., Nye F.J., and Edwards R.H.T. Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. British Medical Journal (2001) 322-1-5
40. Richards R.S., Roberts T.K., McGregor N.R., Dunstan R.H., and Butt H.L. Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Report 5 (2000) 35-41
41. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., et al. Interleukin-1 beta-mediated induction of COX-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410 (2001) 471-475
42. Shephard C. Pacing and exercise in chronic fatigue syndrome. Physiotherapy 87 (2001) 395-396
43. Staud R., Vierck C.J., Cannon R.L., et al. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 91 (2001) 165-175
44. Staud R., Robinson M.E., Vierck Jr. C.J., and Price D.D. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 101 (2003) 167-174
45. Suhadolnik R.J., Peterson D.L., O'Brien K., et al. Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome. Journal of Interferon and Cytokine Research 17 (1997) 377-385
46. Tan E.M., Sugura K., and Gupta S. The case definition of chronic fatigue syndrome. Journal of Clinical Immunology 22 (2002) 8-12
47. Vecchiet J., Cipollone F., Falasca K., Mezzetti A., Pizzigallo E., Bucciarelli T., et al. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neuroscience Letters 335 (2003) 151-154
48. Vikman K.S., Hill R.H., Backström E., Robertson B., and Kristensson K. Interferon-gamma induces characteristics of central sensitization in spinal dorsal horn neurons in vitro. Pain 106 (2003) 241-251
49. Vojdani A., Choppa P.C., Tagle C., Andrin R., Samini B., and Lapp C.W. Detection of Mycoplasma genus and Mycoplasma fermentans by PCR in patients with chronic fatigue syndrome. FEMS Immunology and Medical Microbiology 22 (1998) 355-365
50. Wallmann K.E., Morton A.R., Goodman C., Grove R., and Guilfoyle A.M. Randomised controlled trial of graded exercise in chronic fatigue syndrome. Medical Journal of Australia 180 (2004) 444-448
51. Watkins L.R., and Maier S.F. Implications of immune-to-brain communication for sickness and pain. Proceedings of the National Academy of Science USA 96 (1999) 7710-7713
52. Whiteside A., Hansen S., and Chaudhuri A. Exercise lowers pain threshold in chronic fatigue syndrome. Pain 109 (2004) 497-499
53. Yamamoto S., Ouchi Y., Onoe H., Yoshikawa E., Tsukawa E., Takahashi T., et al. Reduction of serotonin transporters of patients with chronic fatigue syndrome. NeuroReport 15 (2004) 2571-2574
54. Zusman M. Forebrain-mediated sensitization of central pain pathways: 'non-specific' pain and a new image for MT. Manual Therapy 7 (2002) 80-88